Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.

Authors
Type
Published Article
Journal
Cancer Research
1538-7445
Publisher
American Association for Cancer Research
Publication Date
Volume
71
Issue
9
Pages
3317–3327
Identifiers
DOI: 10.1158/0008-5472.CAN-10-2048
PMID: 21402713
Source
Medline

Abstract

Statistics

Seen <100 times